Search bioRxiv⌕ Search

Biology subjects

Morrell, C.

Publications and source records attributed to Morrell, C..

2 recordsLinked to original sources

Protective concentric cardiac proteostasis adaptations to chronic cAMP-stress at young ages wanes in advanced age leading to accelerated cardiac aging

Dysregulated proteostasis, leading to accumulation of misfolded proteins, electron-dense aggregates (lipofuscin, LF), preamyloid oligomers (PAOs), and proteotoxic stress is a hallmark of aging. We investigated how efficiently proteostatic adaptations to chronic cardiac cyclic adenosine monophosphate (cAMP)-dependent stress change with aging in mice harboring marked, cardiac-specific over-expression of adenylyl cyclase VIII (TGAC8). We assessed protein quality control (PQC) mechanisms: ubiquitin proteasome system (UPS), autophagic flux via macroautophagy, and mitophagy in left ventricles (LVs) of TGAC8 and wild type littermates (WT) at 3-4 months and at 17-21 months of age. At 3-4 months of age TGAC8 mice exhibited markers of increased autophagic flux, measured by levels of microtubule-associated protein 1 light chain 3 (LC3), p62, and their phospho-forms in TGAC8 LV; cathepsin L1 activity was also significantly increased. In addition, canonical mitophagy signaling was enhanced, as receptors PARKIN, p62S405 and p62S351 were all upregulated, confirming a more efficient proteostasis in TGAC8 at 3-4 months vs WT. In advanced age, however, the PQC mechanisms were overwhelmed by proteotoxic stress, manifested in insufficient proteasome activity and an unbalanced autophagic flux (accelerated for markers such as LC3A in the context of a slower overall flux), leading to an increase in the accumulation of protein aggregates (increased ratio of insoluble/soluble protein fractions). Although both canonical (PARKIN, p62S405 and p62S351 receptors) and non-canonical (FKBP8 receptor) mitophagy signaling were upregulated in advanced age in TGAC8, mitophagy was markedly impaired and mitochondrial dysfunction increased. Accumulation of LF bodies, of brownish-to-black pigments, and of LC3+ and p62+-inclusions of aberrant sizes, of desmin cardiac preamyloid oligomers (PAOs) and of cleaved desmin, tagged for ubiquitination, were all increased in TGAC8 compared to young TGAC8. In contrast, the rate of protein synthesis and levels of soluble aggregates were reduced in aged vs young TGAC8, a sign of "normal" aging. Thus, increased proteostatic mechanisms maintain cardiac health in TGAC8 in youth (3-4 months), but long-term exposure to chronic cardiac stress, imposed by sustained activation of the AC/cAMP/PKA/Ca2+ signaling axis, results in severely dysregulated proteostasis in TGAC8 vs WT mice, associated with proteostatic insufficiency and increased cardiomyopathy that leads to accelerated cardiac aging. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=171 SRC="FIGDIR/small/553128v3_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@73ff64org.highwire.dtl.DTLVardef@1842158org.highwire.dtl.DTLVardef@1a92684org.highwire.dtl.DTLVardef@1fe596_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗

The Therapeutic Effects of Long-term Photobiomodulation on Aging in Mice

BackgroundWe have reported that photobiomodulation (PBM) therapy, a form of low dose Near Infrared Light (NIR) therapy, attenuates cardiovascular remodeling and extends the lifespan in a mouse model of accelerated cardiac aging. Here, we tested whether long-term PBM affects the aging process in normal male and female mice. MethodsC57 mice, 18 months old, males (n=60) and females (n=60), were exposed to either NIR (850nm) at 25 mW/cm2 for 2 min on weekdays (MT and FT groups) or nothing (M and F groups) for 12 months. Mice were subjected to bimonthly echocardiography examination, Gait analysis and Frailty assessments. Randomly selected mice were sacrificed bimonthly for fresh tissue samples. ResultsAge-associated deterioration in left ventricle, left atrium, aorta, brain blood perfusion, frailty, body temperature and gait that were observed in M and F groups during the 12-month observation period were significantly attenuated by PBM therapy in MT and FT groups. The medium lifespan was extended by 0.6 and 1.0 month in MT and FT groups, compared to M and F groups, respectively. There was a significantly lower prevalence of dermatitis, stroke and heart failure in MT and FT groups compared to M and F groups. ConclusionOur data showed for the first time that PBM therapy by whole body exposure, even started at old age in normal animals, significantly attenuated the age-associated deterioration in heart, vessels, brain, gait and frailty; reduced the prevalence of stroke and heart failure; and improved health span.

physiology↗